US court rules in favour of Affymetrix
Affymetrix executive vice president, general counsel and secretary Rick Runkel said they are pleased that the Federal Circuit has affirmed the District Court’s prior rulings that Affymetrix does
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.